Peter McPherson

Peter McPherson /neuro/taxonomy/term/223/all en Open Science project funded for $1.5M /neuro/channels/news/open-science-project-funded-15m-361131 <h2>YCharOS antibody characterization platform addresses the “reproducibility crisis” in research</h2> An innovative research project led by researchers at The Neuro has been awarded $1.5M by the Government of Quebec through CQDM. YCharOS is an innovative platform led by neuroscientists Peter McPherson and Carl Laflamme that validates antibody reagents for human proteins. Tue, 12 Nov 2024 16:51:24 +0000 shawn.hayward@mcgill.ca 6261 at /neuro Recreating a hallmark of Parkinson's disease in human neurons /neuro/channels/news/recreating-hallmark-parkinsons-disease-human-neurons-360245 <h2>Scientists use stem cells to follow development of protein bodies characteristic of neurological disease</h2> Tue, 08 Oct 2024 14:47:43 +0000 shawn.hayward@mcgill.ca 6213 at /neuro Discovery gives answers to parents of children with rare disease /neuro/article/research/discovery-gives-answers-parents-children-rare-disease Scientists identify gene mutations that cause debilitating neurodevelopmental problems in infancy. Wed, 21 Aug 2024 15:41:07 +0000 Shawn Hayward 6130 at /neuro Open Science antibody characterization project receives $4-million grant /neuro/channels/news/open-science-antibody-characterization-project-receives-4-million-grant-338399 <div> <div> <h2>YCharOS is an independent quality assessment initiative to improve research results </h2> </div> <div> An antibody characterization project with partners at The Neuro will be able to expand thanks to funding from Génome Québec. </div></div> Mon, 14 Mar 2022 19:56:23 +0000 shawn.hayward@mcgill.ca 5389 at /neuro YCharOS forms key industry advisory committee and releases first open data /neuro/channels/news/ycharos-forms-key-industry-advisory-committee-and-releases-first-open-data-331627 Leading antibody reagent and knockout cell line manufacturers team up to address life science reproducibility crisis YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins, is pleased to announce the publication of its first characterization data and formation of its Industry Advisory Committee (IAC). Tue, 22 Jun 2021 13:11:31 +0000 shawn.hayward@mcgill.ca 5035 at /neuro Neuroscience lab turns attention to COVID-19 /neuro/article/research/neuroscience-lab-turns-attention-covid-19 Researchers use their cell biology expertise to understand how the virus enters cells Tue, 16 Jun 2020 00:49:59 +0000 Shawn Hayward 4620 at /neuro Major ALS Research Funding Announced /neuro/channels/news/major-als-research-funding-announced-264310 MNI scientists will study stem cells, genetic mutations to develop new treatments Researchers at the Montreal Neurological Institute of McGill University who are playing key roles in uncovering the mechanisms underlying ALS will share in $3.9 million in research funding, part of $4.5 million announced on Nov. 23 by the ALS Society of Canada in partnership with Brain Canada. Tue, 22 Nov 2016 19:50:02 +0000 shawn.hayward@mcgill.ca 2340 at /neuro ALS – Fostering awareness of a devastating disease /neuro/channels/news/als-fostering-awareness-devastating-disease-268478 ALS takes away the patient’s motor functions one at a time, and the progress of finding effective drugs to counter its insidious effects has been slow. June is ALS Month, a good time to update the public on the latest developments in ALS research taking place at The Neuro. The Montreal Neurological Institute and Hospital (The Neuro) is recognized as a leading Canadian centre for research into amyotrophic lateral sclerosis (ALS) as well as for its care of ALS patients. Fri, 02 Jun 2017 14:59:25 +0000 shawn.hayward@mcgill.ca 2634 at /neuro June is ALS Month /neuro/channels/news/june-als-month-287550 A look at the latest ALS research and clinical care at The Neuro Amyotrophic lateral sclerosis (ALS) is a terrible disease with no known cure. Research at The Montreal Neurological Institute and Hospital (The Neuro) is uncovering data that could help find effective treatments for ALS. Thu, 07 Jun 2018 14:55:40 +0000 shawn.hayward@mcgill.ca 3076 at /neuro Using patients’ own cells to accelerate research into neurological disease /neuro/channels/news/using-patients-own-cells-accelerate-research-neurological-disease-244516 $1 M gift from Mr. J. Sebastian van Berkom launches translational research into neurological disease A patient’s very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson’s and other neurological diseases. Tue, 31 Mar 2015 13:29:50 +0000 anita.kar@mcgill.ca 1395 at /neuro ALS Awareness Month – June /neuro/channels/news/als-awareness-month-june-253218 As a major Canadian centre for amyotrophic lateral sclerosis (ALS) research and treatment, the Montreal Neurological Institute and Hospital - The Neuro, invites the public and the media to learn more about the disease and current research and treatments, to donate money for ALS research and to wear the national emblem of ALS in Canada, the blue cornflower, during ALS Awareness Month in June. Tue, 02 Jun 2015 14:36:53 +0000 anita.kar@mcgill.ca 1500 at /neuro Scientists and Clinicians at The Montreal Neurological Institute and Hospital receive funding for ALS research /neuro/channels/news/scientists-and-clinicians-montreal-neurological-institute-and-hospital-receive-funding-als-research-256906 The ALS Ice Bucket Challenge One Year Later On November 19 2015, marking the anniversary of the announcement of the 2014 ALS Ice Bucket Challenge results and partnership between ALS Canada and Brain Canada, ALS Canada was at The Montreal Neurological Institute and Hospital – The Neuro, to announce the final recipients of their 2015 grant competition. Four researchers and clinicians at The Neuro were among those recipients for their groundbreaking work in the ALS research field. Fri, 20 Nov 2015 15:46:55 +0000 maya-olivia.eyssen@mcgill.ca 1826 at /neuro ALS Awareness Month – June 2016 /neuro/ALS-Month-2016 The Neuro is recognized as a major Canadian center for ALS research and patient care. During June, designated ALS Month, The Neuro redoubles its efforts to inform the public and the media about amyotrophic lateral sclerosis (ALS), and urges all to help support ALS research. Fri, 10 Jun 2016 20:45:35 +0000 shawn.hayward@mcgill.ca 2101 at /neuro MNI researchers receive funding to study ARSACS /neuro/channels/news/mni-researchers-receive-funding-study-arsacs-264344 Two researchers at the Montreal Neurological Institute and Hospital (MNI) of McGill University have received funding to study a devastating neurodegenerative disease that first appears in toddlers just as they are beginning to walk. Thu, 24 Nov 2016 16:53:42 +0000 shawn.hayward@mcgill.ca 2350 at /neuro The Neuro and Thermo Fisher Scientific Partner to Fight Neurodegenerative Disease /neuro/channels/news/neuro-and-thermo-fisher-scientific-partner-fight-neurodegenerative-disease-285574 Industry and academia to share expertise in effort to develop improved methods to produce and characterize antibodies and reagents for neurological research Mon, 05 Mar 2018 15:12:01 +0000 shawn.hayward@mcgill.ca 2935 at /neuro